Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration

Purpose GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown. Methods Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hair...

Full description

Saved in:
Bibliographic Details
Published inCellular oncology (Dordrecht) Vol. 47; no. 4; pp. 1391 - 1403
Main Authors Tao, Chen-Yang, Wu, Xiao-Ling, Song, Shu-Shu, Tang, Zheng, Zhou, Yu-Fu, Tian, Meng-Xin, Jiang, Xi-Fei, Fang, Yuan, Zhu, Gui-Qi, Huang, Run, Qu, Wei-Feng, Gao, Jun, Chu, Tian-Hao, Yang, Rui, Chen, Jia-Feng, Zhao, Qian-Fu, Ding, Zhen-Bin, Dai, Zhi, Zhou, Jian, Liu, Wei-Ren, Shi, Ying-Hong, Fan, Jia
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.08.2024
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown. Methods Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry. Results The GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8. Conclusion The findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC.
AbstractList GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown. Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry. The GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8. The findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC.
GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown.PURPOSEGPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown.Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry.METHODSImmunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry.The GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8.RESULTSThe GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8.The findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC.CONCLUSIONThe findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC.
Purpose GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown. Methods Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry. Results The GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8. Conclusion The findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC.
PurposeGPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown.MethodsImmunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry.ResultsThe GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8.ConclusionThe findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC.
Author Zhou, Jian
Zhu, Gui-Qi
Zhou, Yu-Fu
Jiang, Xi-Fei
Fan, Jia
Liu, Wei-Ren
Tang, Zheng
Huang, Run
Wu, Xiao-Ling
Tao, Chen-Yang
Chu, Tian-Hao
Qu, Wei-Feng
Dai, Zhi
Gao, Jun
Chen, Jia-Feng
Shi, Ying-Hong
Zhao, Qian-Fu
Song, Shu-Shu
Yang, Rui
Fang, Yuan
Tian, Meng-Xin
Ding, Zhen-Bin
Author_xml – sequence: 1
  givenname: Chen-Yang
  surname: Tao
  fullname: Tao, Chen-Yang
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 2
  givenname: Xiao-Ling
  surname: Wu
  fullname: Wu, Xiao-Ling
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 3
  givenname: Shu-Shu
  surname: Song
  fullname: Song, Shu-Shu
  organization: Department of Biochemistry and Molecular, School of Basic Medical Sciences, Fudan University
– sequence: 4
  givenname: Zheng
  surname: Tang
  fullname: Tang, Zheng
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 5
  givenname: Yu-Fu
  surname: Zhou
  fullname: Zhou, Yu-Fu
  organization: Department of Immunology and Pathogenic Biology, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine
– sequence: 6
  givenname: Meng-Xin
  surname: Tian
  fullname: Tian, Meng-Xin
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 7
  givenname: Xi-Fei
  surname: Jiang
  fullname: Jiang, Xi-Fei
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 8
  givenname: Yuan
  surname: Fang
  fullname: Fang, Yuan
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 9
  givenname: Gui-Qi
  surname: Zhu
  fullname: Zhu, Gui-Qi
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 10
  givenname: Run
  surname: Huang
  fullname: Huang, Run
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 11
  givenname: Wei-Feng
  surname: Qu
  fullname: Qu, Wei-Feng
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 12
  givenname: Jun
  surname: Gao
  fullname: Gao, Jun
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 13
  givenname: Tian-Hao
  surname: Chu
  fullname: Chu, Tian-Hao
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 14
  givenname: Rui
  surname: Yang
  fullname: Yang, Rui
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 15
  givenname: Jia-Feng
  surname: Chen
  fullname: Chen, Jia-Feng
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 16
  givenname: Qian-Fu
  surname: Zhao
  fullname: Zhao, Qian-Fu
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 17
  givenname: Zhen-Bin
  surname: Ding
  fullname: Ding, Zhen-Bin
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 18
  givenname: Zhi
  surname: Dai
  fullname: Dai, Zhi
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 19
  givenname: Jian
  surname: Zhou
  fullname: Zhou, Jian
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 20
  givenname: Wei-Ren
  surname: Liu
  fullname: Liu, Wei-Ren
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 21
  givenname: Ying-Hong
  surname: Shi
  fullname: Shi, Ying-Hong
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
– sequence: 22
  givenname: Jia
  surname: Fan
  fullname: Fan, Jia
  email: fan.jia@zs-hospital.sh.cn
  organization: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38607517$$D View this record in MEDLINE/PubMed
BookMark eNp9kctO3DAUhq2KqkOnvEAXyBIbNml9y4nDBiFKKdJIsGglxMbyOM5glNiDnTDq2-Nh6FBY4IVt6XznP5f_M9rxwVuEvlLyjRJSfU-UC8IKwkRBSM1FsfqAdhmjtOCCw872z-QE7aV0R_IRQKGET2jCJZCqpNUuuvkRVj7axdjpwQWPQ4vPr64ldh7f2qUegrFdl4MRGx2N86HXR9j1S20GnPFh7EPEabC9tylh7Rvcu0V80vqCPra6S3bv-Z2iPz_Pfp_-KmaX5xenJ7PCCAZDvnkDppo3nEvdcEM5SLAl1HPRzk0NYAUTpmxYU0JbM0sBDFSCCMoyBSWfouON7nKc97Yx1g9Rd2oZXa_jXxW0U68j3t2qRXhQlHLGWF7eFB0-K8RwP9o0qN6l9eDa2zAmxQmXQtBKrosdvEHvwhh9ni9TNZNCUlFlav__lra9_Nt7BtgGMDGkFG27RShRa3_Vxl-V_VVP_qpVTuKbpJRhv7DxpfY7WY-Ehaf2
Cites_doi 10.4252/wjsc.v12.i11.1410
10.1242/jcs.113.16.2845
10.1016/j.jmb.2010.12.039
10.1111/1759-7714.13671
10.1002/hep.22393
10.1186/s12935-020-01692-z
10.1111/j.1440-1746.2007.05040.x
10.1080/15384047.2022.2108690
10.1016/j.freeradbiomed.2014.01.018
10.7150/jca.9215
10.1016/j.cellsig.2022.110350
10.1515/hsz-2020-0286
10.1161/ATVBAHA.109.193631
10.12659/msm.921775
10.1158/0008-5472.Can-08-1573
10.3322/caac.21660
10.1073/pnas.2010275117
10.4149/neo_2011_03_239
10.1136/gutjnl-2013-304612
10.1042/BJ20050412
10.1038/nm.4409
10.1038/nrdp.2016.18
10.1016/j.pharmthera.2012.08.014
10.21037/hbsn-22-469
10.1056/NEJMra1713263
10.1038/s41392-021-00828-5
10.1093/carcin/bgu083
10.1186/s12916-019-1341-6
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
5PM
DOI 10.1007/s13402-024-00934-w
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2211-3436
EndPage 1403
ExternalDocumentID PMC11322209
38607517
10_1007_s13402_024_00934_w
Genre Journal Article
GrantInformation_xml – fundername: Shanghai Municipal Key Clinical Specialty. CAMS Innovation Fund for Medical Sciences (CIFMS)
  grantid: 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058; 2019-I2M-5-058
– fundername: Shanghai Municipal Science and Technology Major Project
  grantid: 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05; 2018SHZDZX05
– fundername: National Key R&D Program of China
  grantid: 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100; 2018YFC1312100
– fundername: Shanghai Municipal Health Commission
  grantid: 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221; 202040221
– fundername: Clinical Research Plan of SHDC
  grantid: No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007; No. SHDC2020CR5007
– fundername: National Natural Science Foundation of China
  grantid: 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217; 82073217
– fundername: National Key R&D Program of China
  grantid: 2018YFC1312100
– fundername: Shanghai Municipal Science and Technology Major Project
  grantid: 2018SHZDZX05
– fundername: Clinical Research Plan of SHDC
  grantid: No. SHDC2020CR5007
– fundername: Shanghai Municipal Health Commission
  grantid: 202040221
– fundername: National Natural Science Foundation of China
  grantid: 82073217
– fundername: Shanghai Municipal Key Clinical Specialty. CAMS Innovation Fund for Medical Sciences (CIFMS)
  grantid: 2019-I2M-5-058
GroupedDBID ---
-EM
06D
0R~
0VY
203
29~
2KG
2KM
2VQ
30V
4.4
406
408
53G
67N
8UJ
96X
AAAVM
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AAJSJ
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAYIU
AAYQN
AAYTO
AAYZH
AAZMS
ABAKF
ABDBF
ABDZT
ABECU
ABFTV
ABIPD
ABJNI
ABJOX
ABKCH
ABMQK
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABXPI
ACAOD
ACGFS
ACHSB
ACKNC
ACMDZ
ACMLO
ACOKC
ACPIV
ACPRK
ACUHS
ACULB
ACZOJ
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETCA
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALFXC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
AMYQR
ANMIH
AOCGG
AXYYD
BGNMA
C6C
CSCUP
DDRTE
DNIVK
DPUIP
EAD
EAP
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMK
EMOBN
EPL
ESBYG
ESX
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FYJPI
GGCAI
GGRSB
GJIRD
GQ6
GQ7
H13
HF~
HMJXF
HRMNR
HZ~
I0C
IKXTQ
IMOTQ
ITM
IWAJR
J-C
JBSCW
JZLTJ
KOV
LLZTM
M4Y
NPVJJ
NQJWS
NU0
O9-
O93
O9J
P2P
PT4
R9I
RLLFE
ROL
RSV
S3A
S3B
SBL
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
TSG
TUS
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VFIZW
W48
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABEEZ
ABFSG
ACSTC
AEZWR
AFDZB
AFGXO
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
5PM
ID FETCH-LOGICAL-c426t-c43d6c7bd338ad3c13686e569b4fbc966e424c5d2d56f92e166c6740412e56653
IEDL.DBID U2A
ISSN 2211-3428
2211-3436
IngestDate Thu Aug 21 18:34:54 EDT 2025
Mon Jul 21 09:54:37 EDT 2025
Fri Jul 25 09:52:43 EDT 2025
Mon Jul 21 05:40:58 EDT 2025
Tue Jul 01 04:25:03 EDT 2025
Fri Feb 21 02:38:09 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords GPX8
Hepatocellular carcinoma
Hsc70
Migration
Tumor stemness
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c426t-c43d6c7bd338ad3c13686e569b4fbc966e424c5d2d56f92e166c6740412e56653
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://link.springer.com/10.1007/s13402-024-00934-w
PMID 38607517
PQID 3092848147
PQPubID 2044311
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11322209
proquest_miscellaneous_3038441785
proquest_journals_3092848147
pubmed_primary_38607517
crossref_primary_10_1007_s13402_024_00934_w
springer_journals_10_1007_s13402_024_00934_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-08-01
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-08-01
  day: 01
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Netherlands
PublicationTitle Cellular oncology (Dordrecht)
PublicationTitleAbbrev Cell Oncol
PublicationTitleAlternate Cell Oncol (Dordr)
PublicationYear 2024
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References Khatib, Solaimuthu, Ben Yosef, Abu Rmaileh, Tanna, Oren, Schlesinger Frisch, Axelrod, Lichtenstein, Shaul (CR8) 2020; 117
Peng, Hu, Soutto, Belkhiri, El-Rifai (CR18) 2014; 5
He, Sun, Zhang, Yang, Chen, Xu, Li (CR25) 2021; 6
Villanueva (CR3) 2019; 380
Shiota, Kusakabe, Izumi, Hikita, Nakao, Funae, Miura, Iwao (CR16) 2010; 30
CR17
CR14
Paik, Jung, Heo, Choi, Choi, Kim (CR15) 2008; 23
Ahn, Kim, Yoon, Vacratsis (CR28) 2005; 392
Chen, Xu, Shan, Chen, Hu (CR11) 2020; 20
Zhang, Liu, Guo, Zhao (CR9) 2020; 11
Batlle, Clevers (CR5) 2017; 23
Xie, Zhu, Ren, Zhou, Fan, Gao (CR2) 2023; 12
Dastoor, Dreyer (CR27) 2000; 113
Buday, Conrad (CR21) 2021; 402
Wang, Meng, Sun, Liu, Han, Du, Song, Xu (CR22) 2011; 58
Zhang, Zhan, Li, Wang, Cheng, Yao, Jia (CR20) 2020; 26
Ramming, Hansen, Nagata, Ellgaard, Appenzeller-Herzog (CR7) 2014; 70
Peng, Hu, Soutto, Belkhiri, Zaika, El-Rifai (CR19) 2014; 63
Fleming-de-moraes, Rocha, Tessmann, de Araujo, Morgado-Diaz (CR24) 2022; 23
Ding, Shi, Zhou, Qiu, Xu, Dai, Shi, Wang, Ke, Wu, Fan (CR13) 2008; 68
Daisy Precilla, Biswas, Kuduvalli, Anitha (CR23) 2022; 95
Llovet, Zucman-Rossi, Pikarsky, Sangro, Schwartz, Sherman, Gores (CR4) 2016; 2
Liu, Daniels, Cao (CR26) 2012; 136
Jagust, Alcalá, Sainz, Heeschen, Sancho (CR10) 2020; 12
Sung, Ferlay, Siegel, Laversanne, Soerjomataram, Jemal, Bray (CR1) 2021; 71
Shi, Ding, Zhou, He, Xu, Gambotto, Rabinowich, Fan, Yin (CR12) 2008; 48
Nguyen, Saaranen, Karala, Lappi, Wang, Raykhel, Alanen, Salo, Wang, Ruddock (CR6) 2011; 406
934_CR14
X. Zhang (934_CR20) 2020; 26
T. Liu (934_CR26) 2012; 136
Z.B. Ding (934_CR13) 2008; 68
K. Buday (934_CR21) 2021; 402
D. Peng (934_CR19) 2014; 63
Y.H. Shi (934_CR12) 2008; 48
V.D. Nguyen (934_CR6) 2011; 406
934_CR17
D.Y. Xie (934_CR2) 2023; 12
J.M. Llovet (934_CR4) 2016; 2
A. Khatib (934_CR8) 2020; 117
A. Villanueva (934_CR3) 2019; 380
X.H. Wang (934_CR22) 2011; 58
J. Zhang (934_CR9) 2020; 11
D.F. Peng (934_CR18) 2014; 5
H. Chen (934_CR11) 2020; 20
P. Jagust (934_CR10) 2020; 12
H. Sung (934_CR1) 2021; 71
S.-G. Ahn (934_CR28) 2005; 392
T. Ramming (934_CR7) 2014; 70
K.Y. Paik (934_CR15) 2008; 23
E. Batlle (934_CR5) 2017; 23
M. Shiota (934_CR16) 2010; 30
S. Daisy Precilla (934_CR23) 2022; 95
Z. Dastoor (934_CR27) 2000; 113
Y. He (934_CR25) 2021; 6
C.D. Fleming-de-moraes (934_CR24) 2022; 23
References_xml – volume: 12
  start-page: 1410
  year: 2020
  end-page: 1428
  ident: CR10
  article-title: Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells
  publication-title: World J. Stem. Cells
  doi: 10.4252/wjsc.v12.i11.1410
– volume: 113
  start-page: 2845
  issue: Pt 16
  year: 2000
  end-page: 2854
  ident: CR27
  article-title: Nuclear translocation and aggregate formation of heat shock cognate protein 70 (Hsc70) in oxidative stress and apoptosis
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.113.16.2845
– volume: 406
  start-page: 503
  year: 2011
  end-page: 515
  ident: CR6
  article-title: Two endoplasmic reticulum PDI peroxidases increase the efficiency of the use of peroxide during disulfide bond formation
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2010.12.039
– ident: CR14
– volume: 11
  start-page: 3299
  year: 2020
  end-page: 3308
  ident: CR9
  article-title: GPX8 promotes migration and invasion by regulating epithelial characteristics in non-small cell lung cancer
  publication-title: Thorac Cancer
  doi: 10.1111/1759-7714.13671
– volume: 48
  start-page: 497
  year: 2008
  end-page: 507
  ident: CR12
  article-title: Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence
  publication-title: Hepatology
  doi: 10.1002/hep.22393
– volume: 20
  start-page: 596
  year: 2020
  ident: CR11
  article-title: GPX8 is transcriptionally regulated by FOXC1 and promotes the growth of gastric cancer cells through activating the Wnt signaling pathway
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-020-01692-z
– volume: 23
  start-page: 766
  year: 2008
  end-page: 770
  ident: CR15
  article-title: What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
  publication-title: J. Gastroenterol. Hepatol.
  doi: 10.1111/j.1440-1746.2007.05040.x
– volume: 23
  start-page: 1
  year: 2022
  end-page: 13
  ident: CR24
  article-title: Crosstalk between PI3K/Akt and Wnt/β-catenin pathways promote colorectal cancer progression regardless of mutational status
  publication-title: Cancer Biol. Ther.
  doi: 10.1080/15384047.2022.2108690
– volume: 70
  start-page: 106
  year: 2014
  end-page: 116
  ident: CR7
  article-title: GPx8 peroxidase prevents leakage of H2O2 from the endoplasmic reticulum
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2014.01.018
– volume: 5
  start-page: 510
  year: 2014
  end-page: 517
  ident: CR18
  article-title: Glutathione peroxidase 7 suppresses bile salt-induced expression of pro-inflammatory cytokines in Barrett’s carcinogenesis
  publication-title: J. Cancer
  doi: 10.7150/jca.9215
– volume: 95
  start-page: 110350
  year: 2022
  ident: CR23
  article-title: Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2022.110350
– volume: 402
  start-page: 271
  year: 2021
  end-page: 287
  ident: CR21
  article-title: Emerging roles for non-selenium containing ER-resident glutathione peroxidases in cell signaling and disease
  publication-title: Biol. Chem.
  doi: 10.1515/hsz-2020-0286
– volume: 30
  start-page: 491
  year: 2010
  end-page: 497
  ident: CR16
  article-title: Heat shock cognate protein 70 is essential for Akt signaling in endothelial function
  publication-title: Arteriosclerosis Thrombosis Vasc. Biol.
  doi: 10.1161/ATVBAHA.109.193631
– volume: 26
  start-page: e921775
  year: 2020
  ident: CR20
  article-title: Glutathione peroxidase 8 as aprognostic biomarker of gastric cancer: an analysis of the cancer genome atlas (TCGA) data
  publication-title: Med. Sci. Monit.
  doi: 10.12659/msm.921775
– volume: 68
  start-page: 9167
  year: 2008
  end-page: 9175
  ident: CR13
  article-title: Association of autophagy defect with amalignant phenotype and poor prognosis of hepatocellular carcinoma
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.Can-08-1573
– volume: 71
  start-page: 209
  year: 2021
  end-page: 249
  ident: CR1
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21660
– ident: CR17
– volume: 117
  start-page: 21420
  year: 2020
  end-page: 21431
  ident: CR8
  article-title: The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is essential in maintaining an aggressive breast cancer phenotype
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.2010275117
– volume: 58
  start-page: 239
  year: 2011
  end-page: 244
  ident: CR22
  article-title: Wnt/β-catenin signaling regulates MAPK and Akt1 expression and growth of hepatocellular carcinoma cells
  publication-title: Neoplasma
  doi: 10.4149/neo_2011_03_239
– volume: 63
  start-page: 540
  year: 2014
  end-page: 551
  ident: CR19
  article-title: Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma
  publication-title: Gut.
  doi: 10.1136/gutjnl-2013-304612
– volume: 392
  start-page: 145
  year: 2005
  end-page: 152
  ident: CR28
  article-title: Heat-shock cognate 70 is required for the activation of heat-shock factor 1 in mammalian cells
  publication-title: Biochem. J.
  doi: 10.1042/BJ20050412
– volume: 23
  start-page: 1124
  year: 2017
  end-page: 1134
  ident: CR5
  article-title: Cancer stem cells revisited
  publication-title: Nat. Med.
  doi: 10.1038/nm.4409
– volume: 2
  start-page: 16018
  year: 2016
  ident: CR4
  article-title: Hepatocellular carcinoma
  publication-title: Nat. Rev. Dis. Primers.
  doi: 10.1038/nrdp.2016.18
– volume: 136
  start-page: 354
  year: 2012
  end-page: 374
  ident: CR26
  article-title: Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2012.08.014
– volume: 12
  start-page: 216
  year: 2023
  end-page: 228
  ident: CR2
  article-title: Areview of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights
  publication-title: Hepatobiliary Surg. Nutr.
  doi: 10.21037/hbsn-22-469
– volume: 380
  start-page: 1450
  year: 2019
  end-page: 1462
  ident: CR3
  article-title: Hepatocellular carcinoma
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1713263
– volume: 6
  start-page: 425
  year: 2021
  ident: CR25
  article-title: Targeting PI3K/Akt signal transduction for cancer therapy
  publication-title: Signal Transduct. Target Ther.
  doi: 10.1038/s41392-021-00828-5
– volume: 380
  start-page: 1450
  year: 2019
  ident: 934_CR3
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1713263
– volume: 23
  start-page: 1
  year: 2022
  ident: 934_CR24
  publication-title: Cancer Biol. Ther.
  doi: 10.1080/15384047.2022.2108690
– volume: 30
  start-page: 491
  year: 2010
  ident: 934_CR16
  publication-title: Arteriosclerosis Thrombosis Vasc. Biol.
  doi: 10.1161/ATVBAHA.109.193631
– volume: 392
  start-page: 145
  year: 2005
  ident: 934_CR28
  publication-title: Biochem. J.
  doi: 10.1042/BJ20050412
– volume: 23
  start-page: 1124
  year: 2017
  ident: 934_CR5
  publication-title: Nat. Med.
  doi: 10.1038/nm.4409
– volume: 23
  start-page: 766
  year: 2008
  ident: 934_CR15
  publication-title: J. Gastroenterol. Hepatol.
  doi: 10.1111/j.1440-1746.2007.05040.x
– volume: 58
  start-page: 239
  year: 2011
  ident: 934_CR22
  publication-title: Neoplasma
  doi: 10.4149/neo_2011_03_239
– ident: 934_CR17
  doi: 10.1093/carcin/bgu083
– volume: 136
  start-page: 354
  year: 2012
  ident: 934_CR26
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2012.08.014
– volume: 20
  start-page: 596
  year: 2020
  ident: 934_CR11
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-020-01692-z
– volume: 63
  start-page: 540
  year: 2014
  ident: 934_CR19
  publication-title: Gut.
  doi: 10.1136/gutjnl-2013-304612
– volume: 48
  start-page: 497
  year: 2008
  ident: 934_CR12
  publication-title: Hepatology
  doi: 10.1002/hep.22393
– volume: 68
  start-page: 9167
  year: 2008
  ident: 934_CR13
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.Can-08-1573
– volume: 11
  start-page: 3299
  year: 2020
  ident: 934_CR9
  publication-title: Thorac Cancer
  doi: 10.1111/1759-7714.13671
– ident: 934_CR14
  doi: 10.1186/s12916-019-1341-6
– volume: 95
  start-page: 110350
  year: 2022
  ident: 934_CR23
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2022.110350
– volume: 12
  start-page: 216
  year: 2023
  ident: 934_CR2
  publication-title: Hepatobiliary Surg. Nutr.
  doi: 10.21037/hbsn-22-469
– volume: 113
  start-page: 2845
  issue: Pt 16
  year: 2000
  ident: 934_CR27
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.113.16.2845
– volume: 117
  start-page: 21420
  year: 2020
  ident: 934_CR8
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.2010275117
– volume: 406
  start-page: 503
  year: 2011
  ident: 934_CR6
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2010.12.039
– volume: 2
  start-page: 16018
  year: 2016
  ident: 934_CR4
  publication-title: Nat. Rev. Dis. Primers.
  doi: 10.1038/nrdp.2016.18
– volume: 70
  start-page: 106
  year: 2014
  ident: 934_CR7
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2014.01.018
– volume: 12
  start-page: 1410
  year: 2020
  ident: 934_CR10
  publication-title: World J. Stem. Cells
  doi: 10.4252/wjsc.v12.i11.1410
– volume: 26
  start-page: e921775
  year: 2020
  ident: 934_CR20
  publication-title: Med. Sci. Monit.
  doi: 10.12659/msm.921775
– volume: 5
  start-page: 510
  year: 2014
  ident: 934_CR18
  publication-title: J. Cancer
  doi: 10.7150/jca.9215
– volume: 402
  start-page: 271
  year: 2021
  ident: 934_CR21
  publication-title: Biol. Chem.
  doi: 10.1515/hsz-2020-0286
– volume: 6
  start-page: 425
  year: 2021
  ident: 934_CR25
  publication-title: Signal Transduct. Target Ther.
  doi: 10.1038/s41392-021-00828-5
– volume: 71
  start-page: 209
  year: 2021
  ident: 934_CR1
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21660
SSID ssj0000461656
Score 2.3484025
Snippet Purpose GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma...
GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC)...
PurposeGPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1391
SubjectTerms 1-Phosphatidylinositol 3-kinase
AKT protein
Animals
Antitumor activity
Biomedical and Life Sciences
Biomedicine
Cancer Research
Carcinoma, Hepatocellular - genetics
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - pathology
Cell Line, Tumor
Cell migration
Cell Movement - genetics
Down-regulation
Down-Regulation - genetics
Endoplasmic reticulum
Female
Gene Expression Regulation, Neoplastic
Glutathione
Glutathione Peroxidase - genetics
Glutathione Peroxidase - metabolism
Heat shock proteins
Hepatocellular carcinoma
Hsc70 protein
Humans
Immunoprecipitation
Kinases
KLF4 protein
Kruppel-Like Factor 4
Liver cancer
Liver Neoplasms - genetics
Liver Neoplasms - metabolism
Liver Neoplasms - pathology
Male
Mass spectroscopy
Mice
Mice, Inbred BALB C
Mice, Nude
Middle Aged
Neoplastic Stem Cells - metabolism
Neoplastic Stem Cells - pathology
Oct-4 protein
Oncology
Pathology
Phosphorylation
Pluripotency
Protein arrays
Protein transport
Proteins
Proto-Oncogene Proteins c-akt - metabolism
Signal transduction
Signal Transduction - genetics
Therapeutic targets
Transcriptomes
Tumors
Title Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration
URI https://link.springer.com/article/10.1007/s13402-024-00934-w
https://www.ncbi.nlm.nih.gov/pubmed/38607517
https://www.proquest.com/docview/3092848147
https://www.proquest.com/docview/3038441785
https://pubmed.ncbi.nlm.nih.gov/PMC11322209
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9NADLbYXSFxQbwJLNUgcYNIybzDrSr7EAjEgUqFS5TMTHZ7aIK6qVb779fOo1VZOHDJZZxJYntie8b-DPAucJ9VZcCFZCoTy5SbOEuqJC54YrwMSpquHdDXb_p8Lj8v1GIoCrsas93HI8nuT70rdhOSsmW5jCkMl_H1ARwpjN0pkWvOp9udFYIQ113bVs4Jow8d7KFa5u_T7FukO27m3WzJP45MO0t0-ggeDi4km_Yyfwz3Qv0E7vdNJW-ewq9PGFiv-xbzyHTWVOzs-8KyZc0u0fa0De3VU_Ipc9RHqG5WxUfWF0syJG83q2bNCN6ZfoKsqD1bLS96PXkG89OTH7PzeOigEDu0vC1ehdfOlB4D0cILlwptdVA6K2VVOox0guTSKc-90lXGQ6q100YSBhdSaSWew2Hd1OElsMw6rXAOYUorfWVs5tO0lLay2ghVuAjej1zMf_dAGfkOEpl4niPP847n-XUExyOj82HRXOUiyTih-0sTwdvtMKo78aWoQ7MhGmGpa5pVEbzo5bJ9nLAaHaAU77Z7EtsSEJT2_ki9vOwgtdPuxCnJIvgwCnf3Xv_-jFf_R_4aHvBO8Sh_8BgO2_UmvEGfpi0ncDQ9-_nlZAIHMz2bdAp9C0ty8FI
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9swDCa6FMN2KbpX6z42DdhtM2Dr7d6CPpZmbTFgLRDsYtiS3OYQe0gdFPv3o_xIkLU77OKLaNkmKZOUyI8Anxy1SZE7XEiqUCGPqQqTqIjCjEbKcie4atoBXV7J0Q0fT8SkKwq777Pd-yPJ5k-9KnZj3GfLUh76MJyHD89gUwupxQA2h8Pxj_Fyb8WDiMumcSulHqUPXeyuXubpidZt0iNH83G-5F-Hpo0tOtuGrc6JJMNW6q9gw5Wv4XnbVvL3G_h5gqH1vG0yj2wnVUG-fp9oMi3JHVqfuvK79T79lBjfSaisZtkRacslCZLXi1k1Jx7g2f8GSVZaMpvetpryFm7OTq-PR2HXQyE0aHtrvDIrjcothqKZZSZmUksnZJLzIjcY6zhOuRGWWiGLhLpYSiMV9yhcSCUFeweDsirdLpBEGylwDqZyzW2hdGLjOOe60FIxkZkAPvdcTH-1UBnpChTZ8zxFnqcNz9OHAA56RqfdsrlPWZRQj-_PVQAfl8Oo8J4vWemqhadh2vdN0yKAnVYuy8cxLdEFivFuvSaxJYEH014fKad3Dah23Jw5RUkAX3rhrt7r35-x93_kH-DF6PryIr04v_q2Dy9po4Q-m_AABvV84Q7Rw6nz951C_wGS5_Ig
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9RADLagCMQFlXegwCBxg6jJvNNb1bKUV9UDK624RMk86B52Ui1ZVfx7xpN9dCkcuOQyziSxPbE9Y38GeOOorXzr4kJSXuW8pCqvCl_kDS2U5U5wldoBfT2VJ2P-aSImV6r4U7b76khyqGlAlKbQ719Yv78pfGMcM2cpzzEk5_nlTbjFsRo4avSYHq53WRBOXKYWrpQiXl90tpeVM3-fZts6XXM5r2dO_nF8mqzSaBfuLd1JcjjI_z7ccOEB3B4aTP56CN-PY5A9H9rNRwGQzpMPZxNNpoGcRzvUd7hvj4moxGBPodDNmgMyFE6SSN4vZt2cINQz_hBJEyyZTX8MOvMIxqP3345O8mU3hdxEK9zHK7PSqNbGoLSxzJRMaumErFruWxOjHscpN8JSK6SvqCulNFJxxOOKVFKwx7ATuuCeAqm0kSLOwVSrufVKV7YsW669loqJxmTwdsXF-mIAzag38MjI8zryvE48ry8z2Fsxul4uoJ81KyqKSP9cZfB6PRxVH_nSBNctkIZp7KCmRQZPBrmsH8e0jM5QGe_WWxJbEyCs9vZImJ4neO0ynT4VVQbvVsLdvNe_P-PZ_5G_gjtnx6P6y8fTz8_hLk06iGmFe7DTzxfuRXR1-vZl0ubfTc_1Bw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Downregulation+of+GPX8+in+hepatocellular+carcinoma%3A+impact+on+tumor+stemness+and+migration&rft.jtitle=Cellular+oncology+%28Dordrecht%29&rft.au=Tao%2C+Chen-Yang&rft.au=Wu%2C+Xiao-Ling&rft.au=Song%2C+Shu-Shu&rft.au=Tang%2C+Zheng&rft.date=2024-08-01&rft.issn=2211-3428&rft.eissn=2211-3436&rft.volume=47&rft.issue=4&rft.spage=1391&rft.epage=1403&rft_id=info:doi/10.1007%2Fs13402-024-00934-w&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s13402_024_00934_w
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-3428&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-3428&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-3428&client=summon